Meeting
2023 ASCO Annual Meeting
Frailty IO: Frailty parameters and incidence of immune related adverse events in older patients treated with immune checkpoint blockers (ICB).
Authors
Capucine Baldini
Drug Development Department (DITEP), Gustave Roussy, Villejuif, France
Capucine Baldini , Bérengère Beauplet , Lauren Seknazi , Arnaud Pages , Marie Vanneste , Sandrine Estivin , Nicolas Saint Alme , Vincent Goldschmidt , Maxime Frelaut , Aymeric Kisserli , Sarah Guitteny , Celine Nagera Lazarovici , Rachid Mahmoudi , Coline Montegut , Julieta Rodriguez , Anne-Laure Couderc , Elena Paillaud , Florence Canoui-Poitrine
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Geriatric Models of Care
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 12062)
DOI
10.1200/JCO.2023.41.16_suppl.12062
Abstract #
12062
Poster Bd #
430
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Prognostic role of geriatric assessment (GA) in patients with metastatic prostate cancer (MPCaP) attended in medical oncology.
First Author: Regina Girones
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Efficacy and tolerability of immune checkpoint inhibitors in elderly patients with MSI/dMMR gastrointestinal cancers and impact of toxicities on efficacy: The immunoMSI cohort.
First Author: Leah Mailly-Giacchetti
Poster
2019 ASCO Annual Meeting
Is immunotherapy toxicity associated with improved overall survival among older adults with advanced cancer?
First Author: Andrew Johns
Poster
2018 Gastrointestinal Cancers Symposium
Impact of age and frailty on survival in older adults with squamous cell carcinoma of the anus.
First Author: Daniel Yokom